VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever. - Wikidata - awgldk - TriplyDB

VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

http://www.wikidata.org/entity/Q33723534

about

Agility in adversity: Vaccines on Demand Evolutionary ecology of virus emergence.In silico Identification of Potential Peptides or Allergen Shot Candidates Against Aspergillus fumigatus The omic approach to parasitic trematode research-a review of techniques and developments within the past 5 years.The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis.iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines.Q-vaxcelerate: A distributed development approach for a new Coxiella burnetii vaccine.Innovation, urgency and acceptance at the 9th Vaccine Renaissance.New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and Glue.

P2860

Q26252583-A40935D2-EC86-41A4-AF0B-CE0A3ADF7E95 Q30396932-940308E8-9A74-4FF7-A3D6-4C2FDCF0F80B Q37424930-6F68B416-B16F-4946-BB08-FECBE6119D5B Q38820297-6F713E1A-0FF0-4DDC-AB78-EFE0A9D827E6 Q39014347-2D27CEE2-8DA0-4020-8589-A2ED0C8A5367 Q41117694-C626A0A4-477E-4C7F-AB3B-32B7DFE41DF4 Q41929449-0E55A122-90C0-4D73-B986-3956590A97AC Q50285179-48B106F1-E734-4BAD-92B0-02E3D8513547 Q55668744-37C2FF8B-D553-4B28-B907-513BDC4B9213

P2860

VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

http://www.wikidata.org/entity/Q33723534

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

@ast

VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

@en

type

label

VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

@ast

VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

@en

prefLabel

VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

@ast

VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

@en

P1433

Q33723534-3086BEA2-9217-4F71-8B98-7C2ED236416B

P1476

Q33723534-7D731C8B-D42A-4CC7-A70F-CCD5F9074DD4

P2093

Q33723534-0173D14F-C7E1-43DF-832B-6D7790DB59F2

Q33723534-050CE372-F5C4-43C3-A537-83E0D4EA3CD1

Q33723534-0CBAD4FE-5FD8-48EC-9D2D-A00E95E32E80

Q33723534-1E11917F-1960-4665-9152-85C98EFEFF1D

Q33723534-1EA50F08-F3C0-4C01-9CB2-E18DDC8B4EFB

Q33723534-359C5116-31B9-4713-B7DE-A80E6364CA87

Q33723534-38E1EC88-6FBD-47F4-9DE4-576BD453457B

Q33723534-39FA025A-3C3A-4B67-B8E8-F964C4AEA591

Q33723534-3C350EFA-FFBB-4C36-AE04-B7C6C7F619B7

Q33723534-3C557606-0EF3-4A5E-A39D-F33FB2FF432E

P2860

Q33723534-01AA9407-3CC9-4589-9554-626D3D5EBCC6

Q33723534-022367B5-133E-4B75-8294-A450FB84A5AB

Q33723534-09490E8A-4E43-40C4-AAF6-E50ABCBDD33E

Q33723534-0E5805D7-B053-481B-8F90-B3C9DD90B894

Q33723534-158BA996-6225-4910-A580-C3F984061A12

Q33723534-1862215A-D199-41ED-BADA-FCE0429201D9

Q33723534-19A965A5-7D56-402C-B6DA-14C46359CD0D

Q33723534-1BCC734E-E60A-4CFE-93D7-F75320EFE35D

Q33723534-1D479280-175B-4DE9-9C0C-519AFC2D99DD

Q33723534-1F861DD2-1705-40B2-BF3A-90E431D2D8AB

P304

Q33723534-4862E22B-1177-474E-B6F6-4233F12F9DFD

P31

Q33723534-D458FDEB-9754-42FA-8E18-7C6317D62C5F

P356

Q33723534-5EB3FEE2-763E-403D-BA6B-A1107624567A

P433

Q33723534-A6082041-32F7-4324-B904-1AD245452E6C

P478

Q33723534-8BDC5793-0F71-4175-BA95-C18FB969AEFA

P50

Q33723534-45F239C5-340F-4673-A9EA-1210AE9E7294

Q33723534-FE5D9DFE-ACB5-4A56-8251-A31687A22B3F

P577

Q33723534-1D4E0FA2-1E8B-4869-8610-F61A51DEC4EA

P5875

Q33723534-B8F1B3C2-742E-424E-ADB5-3ADCE32D994C

P698

Q33723534-B5CB3FE3-2E12-4725-B8EF-1E2AB02B2322

P921

Q33723534-AAD96B1A-5EFE-4E5D-8125-2708634A7FC5

Q33723534-BF0871D4-12D9-42A9-8180-642CDDF332D0

Q33723534-D0390F3B-1313-4329-B48F-3D61EA1BC692

P932

Q33723534-6DD868D5-5D45-472F-B321-42D282DEB8D8

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

VaxCelerate II: rapid development of a self-assembling vaccine for Lassa fever.

@en

P2093

Brandon Zeigler

http://www.w3.org/2001/XMLSchema#string

Christine Boyle

http://www.w3.org/2001/XMLSchema#string

Cybelle Luza

http://www.w3.org/2001/XMLSchema#string

Dale E Mais

http://www.w3.org/2001/XMLSchema#string

Daniel Richer

http://www.w3.org/2001/XMLSchema#string

David Baker

http://www.w3.org/2001/XMLSchema#string

Eric A Berg

http://www.w3.org/2001/XMLSchema#string

H Shaw Warren

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Gelfand

http://www.w3.org/2001/XMLSchema#string

Jianping Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a new vaccine for the prevention of Lassa fever.

A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans

Lassa fever virus peptides predicted by computational analysis induce epitope-specific cytotoxic-T-lymphocyte responses in HLA-A2.1 transgenic mice.

A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins.

The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 kDa protein with monospecific antiserum

Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice

70-kDa heat shock proteins: specific interactions with HLA-DR molecules and their peptide fragments.

A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.

A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease.

Lassa fever: implications of T-cell immunity for vaccine development.

P304

3022-3038

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.34413

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Anne Searls De Groot

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269284466

http://www.w3.org/2001/XMLSchema#string

P698

25483693

http://www.w3.org/2001/XMLSchema#string

P921

P932

5443105

http://www.w3.org/2001/XMLSchema#string